tiprankstipranks
Trending News
More News >
Arcus Biosciences Inc (RCUS)
NYSE:RCUS
US Market
Advertisement

Arcus Biosciences (RCUS) Income Statement

Compare
489 Followers

Arcus Biosciences Income Statement

Last quarter (Q2 2025), Arcus Biosciences's total revenue was $160.00M, an increase of 310.26% from the same quarter last year. In Q2, Arcus Biosciences's net income was $-8.00M. See Arcus Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 258.00M$ 117.00M$ 112.00M$ 383.00M$ 78.00M
Gross Profit
$ 258.00M$ 117.00M$ 112.00M$ 383.00M$ 78.00M
Operating Expenses
$ 588.00M$ 457.00M$ 392.00M$ 329.00M$ 202.00M
Depreciation and Amortization
$ 10.00M$ 8.00M$ 6.00M$ 4.00M$ 3.00M
EBITDA
$ -269.00M$ -291.00M$ -258.00M$ 59.00M$ -120.00M
Operating Income
$ -330.00M$ -340.00M$ -280.00M$ 54.00M$ -124.00M
Other Income/Expenses
$ 47.00M$ 39.00M$ 14.00M$ 1.00M$ 1.00M
Pretax Income
$ -283.00M$ -301.00M$ -266.00M$ 55.00M$ -123.00M
Net Income
$ -283.00M$ -307.00M$ -267.00M$ 53.00M$ -123.00M
Per Share Metrics
Basic EPS
$ -3.14$ -4.15$ -3.71$ 0.76$ -2.13
Diluted EPS
$ -3.14$ -4.15$ -3.71$ 0.71$ -2.13
Weighted Average Shares Outstanding
90.10M 74.00M 72.00M 69.35M 54.79M
Weighted Average Shares Outstanding (Diluted)
90.10M 74.00M 72.00M 73.97M 54.79M
Currency in USD

Arcus Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis